晚期胃癌的新兴治疗目标和未来方向:综合性审查
Margherita Ratti1, Elena Orlandi1, Ilaria Toscani1
1Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Cancers
|August 10, 2024
概括
先进的胃癌 (GC) 治疗正在通过新的分子和免疫学点得到改善. 个性化疗法,包括免疫疗法和向药物,为转移性疾病患者提供更好的结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 转移性胃癌 (GC) 是一个重大的临床挑战,治疗选择有限,预后不佳.
- 晚期诊断往往排除了治疗性手术干预的可能性.
- 了解分子和免疫学标准的近期进展正在重塑治疗策略.
研究的目的:
- 审查目前用于转移性胃癌系统治疗的分子和免疫学点.
- 突出最近的进展和胃癌治疗的未来方向.
- 提供对高级GC治疗选择的全面了解.
主要方法:
- 审查当前的临床实践指南和文献.
- 对胃癌免疫学和分子分类的分析.
- 讨论已建立和新兴的治疗点和药物.
主要成果:
- 胃癌分类现在包括编程细胞死亡1 (PD-1),微卫星不稳定性 (MSI) 和人体表皮生长因子受体2 (HER2) 状态.
- 免疫检查点抑制剂与化疗相结合改善了结果.
- 基于分子形状的个性化治疗策略正在成为标准.
结论:
- 鉴定特定的分子和免疫学点,可以在晚期胃癌中进行个性化治疗选择.
- 未来的方法,如循环瘤DNA (ctDNA) 监测,新的向性药物 (FGFR,MET),CAR-T细胞和癌症疫苗具有前景.
- 对当前和未来的治疗策略的全面了解对于改善转移性GC患者的治疗结果至关重要.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
